Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Riddle

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Diabetes, Obesity & Metabolism|July 15, 2015
Glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus insulin glargine 100 U/ml in people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: the EDITION 2 randomized 12-month trial including 6-month extensionH Yki-Järvinen, R M Bergenstal, G B Bolli, et al.
Diabetes, Obesity & Metabolism|June 25, 2014
Modulation of insulin dose titration using a hypoglycaemia-sensitive algorithm: insulin glargine versus neutral protamine Hagedorn insulin in insulin-naïve people with type 2 diabetesP D Home, G B Bolli, C Mathieu, et al.
The Journal of Prevention of Alzheimer'S Disease|October 24, 2023
Initial Experiences with Amyloid-Related Imaging Abnormalities in Patients Receiving Aducanumab Following Accelerated ApprovalM D Howe, K J Britton, H E Joyce, et al.
Diabetes, Obesity & Metabolism|May 29, 2013
Options for prandial glucose management in type 2 diabetes patients using basal insulin: addition of a short-acting GLP-1 analogue versus progression to basal-bolus therapyI B Hirsch, J B Buse, J Leahy, et al.
Diabetologia|November 1, 2011
Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trialZ Punthakee, J Bosch, G Dagenais, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Diabetes, Obesity & Metabolism|July 15, 2015
Glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus insulin glargine 100 U/ml in people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: the EDITION 2 randomized 12-month trial including 6-month extensionH Yki-Järvinen, R M Bergenstal, G B Bolli, et al.
Diabetes, Obesity & Metabolism|June 25, 2014
Modulation of insulin dose titration using a hypoglycaemia-sensitive algorithm: insulin glargine versus neutral protamine Hagedorn insulin in insulin-naïve people with type 2 diabetesP D Home, G B Bolli, C Mathieu, et al.
The Journal of Prevention of Alzheimer'S Disease|October 24, 2023
Initial Experiences with Amyloid-Related Imaging Abnormalities in Patients Receiving Aducanumab Following Accelerated ApprovalM D Howe, K J Britton, H E Joyce, et al.
Diabetes, Obesity & Metabolism|May 29, 2013
Options for prandial glucose management in type 2 diabetes patients using basal insulin: addition of a short-acting GLP-1 analogue versus progression to basal-bolus therapyI B Hirsch, J B Buse, J Leahy, et al.
Diabetologia|November 1, 2011
Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trialZ Punthakee, J Bosch, G Dagenais, et al.
Pageof 7